耐药杆菌:诊断和基于证据的方法
Vaneet Jearth1, Mitali Madhumita Rath2, Abhirup Chatterjee1
1Post Graduate Institute Medical Education and Research, Chandigarh 160012, India.
Diagnostics (Basel, Switzerland)
|September 28, 2023
概括
杆菌 (H. pylori) 的抗菌耐药性正在降低根除成功率. 在治疗前测试H. pylori抗生素敏感性对于有效治疗和对抗这种常见感染至关重要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
背景情况:
- 杆菌 (H. pylori) 感染影响全球一半的人口,是与胃癌相关的I类致癌物.
- 每年H. pylori根除率都在下降,抗菌素耐药性是治疗失败的主要原因.
- 抗生素耐药性增加需要转向个性化H. pylori治疗策略.
研究的目的:
- 审查H. pylori抗生素耐药性模式,机制和临床意义.
- 评估目前检测H.pylori的方法及其抗菌素敏感性.
- 为了比较敏感性引导的疗法与实证疗法用于H. pylori根除.
主要方法:
- 对有关H. pylori抗生素耐药性的现有文献的综述.
- 基于传统文化和现代分子诊断技术的分析.
- 针对量身定制的临床结果与实证 H. pylori 治疗方法的临床结果的比较.
主要成果:
- 杆菌表现出多种不同的分子机制,使其对多种抗生素产生耐药性.
- 传统的培养方法用于敏感性测试是耗时的.
- 测序技术的进步提供了快速而准确的H. pylori抗生素敏感性测试.
结论:
- 准确的H. pylori抗生素敏感性测试对于成功根除至关重要.
- 与实证治疗相比,受敏感性引导的治疗改善了H. pylori根除率.
- 结合耐药性数据的基于证据的方法对于管理H. pylori感染至关重要.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
435
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
435
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
154
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
154
01:26Peptic Ulcer Disease IV: Management
109
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
109
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
453
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
453
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
452
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
452
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
503
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
503